Be a voice no echo's Profile Page - moomoo Community

Log Out

Be a voice no echo Private

Private

ID: 70213245

Be a voice，not an echo.

Follow

1487

Following

430

Followers

3405

Visitors

Recommended Users

See More

Movers and Shakers

Recommend to you

Follow

You may be interested

Follow

Love to share useful tips

Follow

Be a voice no echo

commented on a stock ·Dec 20 22:26

$Helius Medical Technologies (HSDT.US)$

Be a voice no echo

commented on a stock ·Dec 19 22:57

$DevvStream (DEVS.US)$

Be a voice no echo

commented on a stock ·Dec 19 22:31

$DevvStream (DEVS.US)$

Be a voice no echo

commented on a stock ·Dec 18 20:39

$Polyrizon (PLRZ.US)$

Be a voice no echo

commented on a stock ·Dec 17 22:01

$Quantum Computing (QUBT.US)$

Be a voice no echo

commented on a stock ·Dec 17 21:53

$Quantum Computing (QUBT.US)$

Be a voice no echo

commented on a stock ·Dec 17 01:06

$Nature's Miracle (NMHI.US)$

Be a voice no echo

commented on a stock ·Dec 17 00:03

nothing going on

$Genprex (GNPX.US)$

Be a voice no echo

commented on a stock ·Dec 16 22:38

$Genprex (GNPX.US)$

Be a voice no echo commented on

commented on a stock ·Dec 16 22:19

$Genprex (GNPX.US)$ Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa Gene Therapy in Combination With Tecentriq in Extensive Stage Small Cell Lung Cancer
PR Newswire· 3 mins ago
Genprex Completes Phase 1 Dose Escalation Portion of Acclaim-3 Clinical Trial
Results from Phase 1 Dose Escalation Demonstrate Favorable Safety Profile of REQORSA and Tecentriq in ES-SCLC Patients

1